JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4126
Tempest Therapeutics
TPST
$13.5M
| $185K | ﹤0.01% |
179
+42
| +31% | +$61.3K |
2017 Q2
11 quarters
|
|
|
GAM
4127
General American Investors Company
GAM
$1.53B
| $184K | ﹤0.01% |
6,693
-2
| -0% | -$69 |
2019 Q2
3 quarters
|
|
4128
Lindblad Expeditions
LIND
$2.33B
| $184K | ﹤0.01% |
44,274
+3,666
| +9% | +$47.1K |
2017 Q4
9 quarters
|
|
4129
Phreesia
PHR
$644M
| $184K | ﹤0.01% |
8,770
-21,699
| -71% | -$595K |
2019 Q3
2 quarters
|
|
4130
Centrus Energy
LEU
$2.89B
| $183K | ﹤0.01% |
36,038
+18,788
| +109% | +$124K |
2019 Q4
1 quarter
|
|
|
PCOM
4131
DELISTED
Points.com Inc. Common Shares
PCOM
| $183K | ﹤0.01% |
22,185
-20,591
| -48% | -$301K |
2017 Q2
11 quarters
|
|
4132
First United
FUNC
$283M
| $182K | ﹤0.01% |
12,754
-2,860
| -18% | -$60.3K |
2018 Q2
7 quarters
|
|
4133
Sunoco
SUN
$13.6B
| $182K | ﹤0.01% |
11,612
-49
| -0.4% | -$1.31K |
2014 Q3
22 quarters
|
|
4134
Carlyle Secured Lending
CGBD
$727M
| $181K | ﹤0.01% |
34,654
+20,339
| +142% | +$241K |
2018 Q2
7 quarters
|
|
|
CTK
4135
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
| $181K | ﹤0.01% |
+1,984
| New | +$149K |
2020 Q1
0 quarters
|
|
|
AVDL
4136
DELISTED
Avadel Pharmaceuticals
AVDL
| $180K | ﹤0.01% |
22,700
| – | – |
2018 Q2
7 quarters
|
|
4137
Eastern Company
EML
$150M
| $180K | ﹤0.01% |
9,240
+2,515
| +37% | +$66.6K |
2017 Q4
9 quarters
|
|
4138
SiTime
SITM
$21.4B
| $180K | ﹤0.01% |
+8,263
| New | +$202K |
2020 Q1
0 quarters
|
|
4139
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$162B
| $179K | ﹤0.01% |
37,427
-803,899
| -96% | -$5.18M |
2013 Q2
27 quarters
|
|
4140
Hawthorn Bancshares
HWBK
$281M
| $178K | ﹤0.01% |
11,394
+6,898
| +153% | +$132K |
2019 Q1
4 quarters
|
|
4141
Insteel Industries
IIIN
$577M
| $178K | ﹤0.01% |
13,465
+492
| +4% | +$9.75K |
2016 Q4
13 quarters
|
|
4142
Mistras Group
MG
$658M
| $178K | ﹤0.01% |
41,852
+28,997
| +226% | +$265K |
2017 Q4
9 quarters
|
|
|
STRS
4143
DELISTED
STRATUS PPTYS INC
STRS
| $178K | ﹤0.01% |
10,132
+3,109
| +44% | +$84.9K |
2016 Q4
13 quarters
|
|
4144
WisdomTree US MidCap Fund
EZM
$909M
| $177K | ﹤0.01% |
6,704
-3,093
| -32% | -$114K |
2013 Q2
27 quarters
|
|
4145
Global Water Resources
GWRS
$232M
| $177K | ﹤0.01% |
17,400
+7,072
| +68% | +$86.9K |
2017 Q4
9 quarters
|
|
4146
Prothena Corp
PRTA
$425M
| $177K | ﹤0.01% |
16,512
-57,615
| -78% | -$698K |
2014 Q4
21 quarters
|
|
|
BPMC
4147
PUT
DELISTED
Blueprint Medicines
BPMC
| $175K | ﹤0.01% |
3,000
| – | – |
2019 Q4
1 quarter
|
|
4148
Dr. Reddy's Laboratories
RDY
$10.3B
| $175K | ﹤0.01% |
21,645
+20,825
| +2,540% | +$174K |
2019 Q3
2 quarters
|
|
4149
Stellus Capital Investment Corp
SCM
$209M
| $173K | ﹤0.01% |
23,751
-48,780
| -67% | -$609K |
2019 Q1
4 quarters
|
|
4150
Saga Communications
SGA
$53.3M
| $173K | ﹤0.01% |
6,296
-4,026
| -39% | -$118K |
2017 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.